CXCL12 and myocardial infarction: Wang and colleagues [97] showed that remodeling after MI could be reversed with a therapy combining NPY and mesenchymal stem cells (MSC) in a rat model of MI through a NPY dependent upregulation of CXCL12 gene and others required for mitosis in MSC.